A Randomized Controlled Trial of Intravenous N-acetylcysteine in the Management of Anti-tuberculosis Drug-Induced Liver Injury
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

A Randomized Controlled Trial of Intravenous N-acetylcysteine in the Management of Anti-tuberculosis Drug-Induced Liver Injury

Moosa, Muhammed S;Maartens, Gary;Gunter, Hannah;Allie, Shaazia;Chughlay, Mohamed F;Setshedi, Mashiko;Wasserman, Sean;Hickman, Nicole;Stewart, Annemie;Sonderup, Mark;Spearman, Catherine Wendy;Cohen, Karen;
clinical infectious diseases pp. -
173
sclinicala

Abstract

AbstractBackground. Liver injury is a common complication of first-line anti-tuberculosis therapy. N-acetylcysteine (NAC) is widely used in patients with parac

Keywords

Access

URL:
https://academic.oup.com/cid/advance-article/doi/1...

Citation

ID: 112020
Ref Key: sclinicala
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
112020
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
4/5
Blockchain Upload Locked

Complete all 5 checklist items to tokenize your article

Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store